Active monitoring with or without endocrine therapy for low-risk ductal carcinoma in situ: The COMET randomized clinical trial

Authors

E Shelley Hwang, Department of Surgery, Duke University, Durham, North Carolina.
Terry Hyslop, Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
Thomas Lynch, Department of Surgery, Duke University, Durham, North Carolina.
Marc D. Ryser, Departments of Population Health Sciences and Mathematics, Duke University, Durham, North Carolina.
Anna Weiss, Department of Surgery/Oncology, University of Rochester, Rochester, New York.
Anna Wolf, Alliance Foundation Trials, Boston, Massachusetts.
Kelsey Norris, Alliance Foundation Trials, Boston, Massachusetts.
Meredith Witten, Advocate Health - MidwestFollow
et al

Recommended Citation

Hwang ES, Hyslop T, Lynch T, et al. Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial. JAMA. 2025;333(11):972-980. doi:10.1001/jama.2024.26698

Type

Article

PubMed ID

39665585